Heart Failure Latest News Archive

Use of Both Aspirin and NSAIDs Associated With Incident Heart Failure Risk

Use of Both Aspirin and NSAIDs Associated With Incident Heart Failure Risk

The use of both NSAID and aspirin was positively associated with incident HF in adults with no prior history of CVD.

IABP Devices Being Evaluated By the FDA Due to Battery Complications

IABP Devices Being Evaluated By the FDA Due to Battery Complications

There have been over 75 medical device reports of the cardiac assist Maquet/Datascope IABP devices shutting down while running on battery.

Data Support Efficacy of Heart Failure Hospital Readmissions Reduction Program

Data Support Efficacy of Heart Failure Hospital Readmissions Reduction Program

The US Hospital Readmissions Reduction Program (HRRP) has successfully reduced readmission rates for certain conditions.

Risk for Congestive Heart Failure During Pregnancy in Cancer Survivors

Risk for Congestive Heart Failure During Pregnancy in Cancer Survivors

Investigators sought to determine the incidence of cardiac decompensation during pregnancy in cancer survivors.

Some Antirheumatic Medications May Be Associated With Increased Heart Failure Risk in RA

Some Antirheumatic Medications May Be Associated With Increased Heart Failure Risk in RA

A diagnosis of cardiovascular disease or presence of related biomarkers, as well as the use of antirheumatic drugs may be associated with a higher risk for heart failure in patients with rheumatoid arthritis.

3D Echocardiography May Affect Decision to Implant an ICD in Subset of Patients

3D Echocardiography May Affect Decision to Implant an ICD in Subset of Patients

LVEF values measured with 3DE were stronger predictors of major arrhythmic events than the same values calculated with 2DE.

Treatment for Transthyretin Amyloidosis Granted Orphan Drug Designation

Treatment for Transthyretin Amyloidosis Granted Orphan Drug Designation

The Company expects to start Phase 3 studies for ATTR cardiomyopathy and polyneuropathy in the first half of 2019.

Periprocedural ICD Complication Rates Among Older Adults Hospitalized With Heart Failure

Periprocedural ICD Complication Rates Among Older Adults Hospitalized With Heart Failure

Patients currently or recently hospitalized for heart failure undergoing initial ICD placement experienced a higher rate of composite periprocedural complications compared with those without a recent heart failure hospitalization.

Improving Cardiac Risk Stratification in Acute Syncope

Improving Cardiac Risk Stratification in Acute Syncope

Natriuretic peptides and high-sensitive troponin may be useful for cardiac risk stratification in acute syncope.

Research Gaps Linked to Limited Enrollment of Women in Heart Failure Clinical Trials

Research Gaps Linked to Limited Enrollment of Women in Heart Failure Clinical Trials

Older patients, women, and racial and ethnic minorities are underrepresented in the majority of heart failure (HF) clinical trials.

LVAD in Heart Failure Linked to Improved Glycemic Control

LVAD in Heart Failure Linked to Improved Glycemic Control

HbA1c levels following left ventricular assist device implantation were statistically significantly lower than before surgery.

FDA Fast Track Designation Granted to Praliciguat for HFpEF

FDA Fast Track Designation Granted to Praliciguat for HFpEF

The Company is currently enrolling patients in a randomized, double-blind, placebo-controlled Phase 2 trial; they expect to enroll 175 in total.

Outcomes With Rivaroxaban in Chronic Heart Failure With Underlying CAD

Outcomes With Rivaroxaban in Chronic Heart Failure With Underlying CAD

Rivaroxaban was not superior to placebo for reducing the rate of death, MI, or stroke in patients with chronic heart failure.

Tafamidis Reduces Mortality, Hospitalizations in Transthyretin Amyloid Cardiomyopathy

Tafamidis Reduces Mortality, Hospitalizations in Transthyretin Amyloid Cardiomyopathy

Tafamidis was associated with reduced all-cause mortality and cardiovascular-related complications in patients with transthyretin amyloid cardiomyopathy.

Reducing HF Hospitalization Risk: Antidiabetic Drug Classes Compared

Reducing HF Hospitalization Risk: Antidiabetic Drug Classes Compared

The authors searched for randomized placebo-controlled trials (December 1, 2008 to November 24, 2017) involving 3 pharmacologic classes of antidiabetic medications to compare the effects of these agents on the risk of hospitalization for HF in T2DM patients.

Evaluating Excess Risk for Heart Failure Hospitalization in Type 2 Diabetes

Evaluating Excess Risk for Heart Failure Hospitalization in Type 2 Diabetes

Investigators examined the excess risk for heart failure in patients with type 2 diabetes and compared the risk with that in the general population without diabetes.

Labeling Mix-Up Prompts Recall of HCTZ Bottles That May Contain Another Diuretic

Labeling Mix-Up Prompts Recall of HCTZ Bottles That May Contain Another Diuretic

To date, there have been no reports of any adverse events related to this recall.

Emphysema Associated With Worse Outcomes in Heart Failure

Emphysema Associated With Worse Outcomes in Heart Failure

After 2.1 years of follow-up, 49% of patients who had emphysema on chest CT were readmitted for heart failure and 24% had died.

Entresto Initiation Soon After Acute HF Episode Safe in HFrEF Patients

Entresto Initiation Soon After Acute HF Episode Safe in HFrEF Patients

The Phase 4, randomized, open-label, parallel-group TRANSITION study (N=1002) evaluated the safety and tolerability of Entresto in HFrEF patients after they were stabilized following an acute heart failure episode when treatment was initiated either pre-discharge or post-discharge.

New Clinical Trial Targets Gut Microbiota in Heart Failure

New Clinical Trial Targets Gut Microbiota in Heart Failure

GutHeart, a new ongoing clinical trial, will investigate the potential benefits of treating gut bacteria in heart failure.

AHA Issues Scientific Statement on Managing Chagas Cardiomyopathy

AHA Issues Scientific Statement on Managing Chagas Cardiomyopathy

The most common findings in patients with Chagas cardiomyopathy include cardiac rhythm abnormalities, myocardial abnormalities, aneurysms, and thromboembolism.

Galafold Approved for the Treatment of Adults With Fabry Disease

Galafold Approved for the Treatment of Adults With Fabry Disease

The FDA has approved Galafold for the treatment of adults with a confirmed diagnosis of Fabry disease.

Kapspargo Sprinkle Available to Treat Hypertension, Angina, Heart Failure

Kapspargo Sprinkle Available to Treat Hypertension, Angina, Heart Failure

For patients unable to swallow an intact capsule, the pellets can be sprinkled over soft food (eg, applesauce, yogurt, pudding) or given via a nasogastric (NG) tube.

High-Risk Breast Cancer Patients May Not Be Adherent to Heart Failure Monitoring

High-Risk Breast Cancer Patients May Not Be Adherent to Heart Failure Monitoring

There is a paucity of data regarding the cardiotoxicity and the monitoring adherence habits of patients undergoing treatment with trastuzumab or anthracyclines, commonly used therapies among patients with HER2-positive breast cancer.

Which Drugs Are Effective for Preventing Sudden Cardiac Death in HFrEF?

Which Drugs Are Effective for Preventing Sudden Cardiac Death in HFrEF?

For this study, researchers searched multiple databases for studies in which the effectiveness of various pharmacologic interventions were evaluated in patients with HFrEF.

Pegylated Interferon, Ribavirin May Improve LV Diastolic Dysfunction in Chronic Hepatitis C

Pegylated Interferon, Ribavirin May Improve LV Diastolic Dysfunction in Chronic Hepatitis C

HCV viral eradication resulted in improved left ventricular diastolic dysfunction.

Effect of SGLT2 Inhibitors on Heart Failure-Related Hospitalization, Below-Knee Amputation

Effect of SGLT2 Inhibitors on Heart Failure-Related Hospitalization, Below-Knee Amputation

Canagliflozin vs other SGLT2 inhibitors and non-SLGT2 inhibitors were examined for the risk for heart failure-related hospitalization and below the knee amputation.

Heart Meds Recalled After Discovery of Possible Carcinogenic Impurity

Heart Meds Recalled After Discovery of Possible Carcinogenic Impurity

As valsartan is used to treat various cardiovascular conditions including heart failure and hypertension, patients should continue to take their medications until they have a replacement product,

Heart Failure Risk Increased When Sleep Apnea Not Managed With CPAP

Heart Failure Risk Increased When Sleep Apnea Not Managed With CPAP

When sleep apnea was not managed with continuous positive airway pressure, the risk for heart failure increased, regardless of age.

Intensified, Multifactorial Intervention for Type 2 Diabetes Reduces Risk for Heart Failure

Intensified, Multifactorial Intervention for Type 2 Diabetes Reduces Risk for Heart Failure

Investigators examined the effect of intensified multifactorial intervention on the risk for heart failure-related hospitalization in patients with type 2 diabetes and microalbuminuria.

Clinical Significance of Genetic Variations in CYP2D6 Investigated in HF Patients

Clinical Significance of Genetic Variations in CYP2D6 Investigated in HF Patients

According to HF guidelines, beta-blockers must be titrated to a specific target dose in order to obtain their morbidity and mortality benefit in HF patients.

SGLT2 Inhibitor Use Linked to Lower Risk for Heart Failure, Death in Type 2 Diabetes

SGLT2 Inhibitor Use Linked to Lower Risk for Heart Failure, Death in Type 2 Diabetes

Regardless of presence of preexisting cardiovascular disease, SGLT2 inhibitors were associated with lower risk for death and heart failure.

LV Strain, Hypertrophy Predict Heart Failure in Asymptomatic T2D

LV Strain, Hypertrophy Predict Heart Failure in Asymptomatic T2D

Impaired global longitudinal strain and left ventricular hypertrophy may be predictive of incident heart failure in patients with asymptomatic type 2 diabetes.

Acute Myocarditis Complicated by LVSD Has Different Presentation, Outcomes

Acute Myocarditis Complicated by LVSD Has Different Presentation, Outcomes

Acute myocarditis complicated by left ventricular systolic dysfunction confers a higher risk for cardiac death and heart transplant compared with uncomplicated acute myocarditis.

Neprilysin Inhibition May Reduce Renal Function Deterioration in Comorbid T2D and Chronic Heart Failure

Neprilysin Inhibition May Reduce Renal Function Deterioration in Comorbid T2D and Chronic Heart Failure

This study aimed to examine the efficacy of neprilysin inhibition in treating renal disease in individuals with T2D.

FDA Recall: HeartMate 3™ Outflow Graft Assembly Malfunction

FDA Recall: HeartMate 3 Outflow Graft Assembly Malfunction

The HeartMate 3™ Left Ventricular Assist System has been recalled because of a potential malfunction in the outflow graft assembly that may cause it to twist and close up over time.

Single-Beat Approach Estimates Preload Recruitable Stroke Work Relationship in PAH

Single-Beat Approach Estimates Preload Recruitable Stroke Work Relationship in PAH

A single-beat estimation of preload recruitable stroke work and its coupling with pulmonary arterial load in pulmonary arterial hypertension provided high accuracy for evaluating right ventricular contractility.

AHA: Right-Sided Heart Failure Evaluation, Management Guidelines

AHA: Right-Sided Heart Failure Evaluation, Management Guidelines

The American Heart Association scientific statement offers recommendations on right-sided heart failure regarding physical examination, serum markers, and imaging.

Sleep Apnea Diagnosis in Heart Failure Using Portable Monitor

Sleep Apnea Diagnosis in Heart Failure Using Portable Monitor

Portable sleep monitoring may accurately diagnose sleep apnea in patients who are hospitalized with heart failure.

Sacubitril/Valsartan vs Enalapril for Physical Activity Improvement in HFrEF

Sacubitril/Valsartan vs Enalapril for Physical Activity Improvement in HFrEF

Sacubitril/valsartan was associated with greater improvements in physical and social activities in patients with heart failure with reduced ejection fraction than enalapril.

Sacubitril/Valsartan May Help Preserve Kidney Function in Patients With HFrEF

Sacubitril/Valsartan May Help Preserve Kidney Function in Patients With HFrEF

Compared with the enalapril-treated group, those treated with sacubitril/valsartan were found to have significantly slower kidney decline (-1.3 vs -1.8mL/min/1.73m2 per year; P<0.0001).

ACC and AHA Release 2018 Quality Measures for Cardiac Rehabilitation

ACC and AHA Release 2018 Quality Measures for Cardiac Rehabilitation

New Class 1 recommendations involve the referral of inpatients and outpatients to cardiac rehabilitation programs that include exercise training.

Elamipretide Granted Orphan Drug Status for Barth Syndrome

Elamipretide Granted Orphan Drug Status for Barth Syndrome

The TAZPOWER study is a randomized, double-blind, placebo-controlled Phase 2/3 crossover study evaluating the safety and efficacy of elamipretide (daily subcutaneous injections) in 12 male patients (aged ≥12 years) with genetically-confirmed Barth syndrome.

Entresto Significantly Improves Physical, Social Activity in Heart Failure Patients

Entresto Significantly Improves Physical, Social Activity in Heart Failure Patients

Entresto may improve limitations in physical and social activities in patients with heart failure.

Oral Tx for Transthyretin Cardiomyopathy Meets Primary Endpoint in Study

Oral Tx for Transthyretin Cardiomyopathy Meets Primary Endpoint in Study

Although they acknowledge the preliminary data is subject to further analysis, they say it demonstrates a statistically significant reduction in the combination of all-cause mortality and frequency of cardiovascular-related hospitalizations compared to placebo at 30 months.

Cardiovascular Outcomes of SGLT-2i vs Other Glucose-Lowering Drugs in T2D

Cardiovascular Outcomes of SGLT-2i vs Other Glucose-Lowering Drugs in T2D

A recent study evaluated the effects of SGLT-2i and other glucose-lowering drugs on cardiovascular event outcomes in patients with type 2 diabetes from 6 countries in 3 world regions.

Automated Detection of Atrial Fibrillation Through Smartwatch Technology

Automated Detection of Atrial Fibrillation Through Smartwatch Technology

A Smartwatch band paired with an app records a 30-second single-lead rhythm strip.

Outcomes With Aspirin for Primary Prevention in Heart Failure, Type 2 Diabetes

Outcomes With Aspirin for Primary Prevention in Heart Failure, Type 2 Diabetes

Primary prevention with aspirin may reduce all-cause mortality in patients with heart failure and type 2 diabetes.

LVAD Shared Decision-Making Program Demonstrates Improved Patient Knowledge

LVAD Shared Decision-Making Program Demonstrates Improved Patient Knowledge

A shared decision-making program between patients with end-stage heart failure being considered for destination therapy left ventricular assist device and their caregivers was associated with improvement in patient knowledge.

Rheumatoid Arthritis May Increase HF Hospitalization Risk

Rheumatoid Arthritis May Increase HF Hospitalization Risk

Rheumatoid arthritis may be associated with an increased risk for hospitalization from heart failure.

High-Sensitivity Cardiac Troponin as a Predictor for Incident Heart Failure

High-Sensitivity Cardiac Troponin as a Predictor for Incident Heart Failure

High-sensitivity cardiac troponin is associated with incident heart failure.

Global Pulmonary Vascular Remodeling and Pulmonary Hypertension in Heart Failure

Global Pulmonary Vascular Remodeling and Pulmonary Hypertension in Heart Failure

Researchers discovered an association between global pulmonary vascular remodeling and pulmonary hypertension in patients with heart failure.

ACC Releases Decision Pathway on Heart Failure With Reduced Ejection Fraction

ACC Releases Decision Pathway on Heart Failure With Reduced Ejection Fraction

The American College of Cardiology released a decision pathway addressing 10 pivotal issues in heart failure with reduced ejection fraction.

High-Dose Beta-Blockers Associated With Lower Mortality in HF, Diabetes

High-Dose Beta-Blockers Associated With Lower Mortality in HF, Diabetes

Patients with chronic heart failure and diabetes may have a greater reduction in mortality with higher beta-blocker doses.

Heart Failure Risk May Be Reduced With a Plant-Based Diet

Heart Failure Risk May Be Reduced With a Plant-Based Diet

Incident heart failure hospitalizations were reduced with plant-based diets.

Role of Coffee Consumption in Heart Failure, Stroke Outcomes

Role of Coffee Consumption in Heart Failure, Stroke Outcomes

In addition to known risk factors, coffee consumption reduces the risk of poor outcomes in heart failure and stroke.

Continuous Furosemide Infusion Superior to Bolus Furosemide in Heart Failure

Continuous Furosemide Infusion Superior to Bolus Furosemide in Heart Failure

Researchers compared different administrations of furosemide in patients with acute decompensated heart failure.

Heart Failure Outcomes Improved With TAVR or SAVR

Heart Failure Outcomes Improved With TAVR or SAVR

Patients with heart failure who received transcatheter aortic valve replacements saw decrease in aortic valve mean gradient.

HFrEF: Similar Effects With Below-Target and Target Enalapril Doses

HFrEF: Similar Effects With Below-Target and Target Enalapril Doses

A study examined whether patients with heart failure with reduced ejection fraction who do not tolerate a high enalapril dose may still benefit from lower doses.

Lower Afib Risk With AdaptivCRT vs Conventional Cardiac Resynchronization Therapy

Lower Afib Risk With AdaptivCRT vs Conventional Cardiac Resynchronization Therapy

Patients who received synchronized left ventricular pacing with the AdaptivCRT had a lower risk of developing atrial fibrillation compared with patients who received conventional cardiac resynchronization therapy.

Sacubitril/Valsartan Increases Physical Activity in Systolic Heart Failure

Sacubitril/Valsartan Increases Physical Activity in Systolic Heart Failure

Patients with systolic heart failure see physical benefits with sacubitril/valsartan.

Heart Failure Outcomes Not Improved With NT-proBNP Treatment Strategy

Heart Failure Outcomes Not Improved With NT-proBNP Treatment Strategy

High-risk patients with heart failure and reduced ejection fraction did not benefit from an amino-terminal pro-B-type natriuretic peptide-guided treatment strategy compared with usual care.

SGLT2 vs DPP4 Medications Associated with Lower Heart Failure Hospitalizations in Type 2 Diabetes

SGLT2 vs DPP4 Medications Associated with Lower Heart Failure Hospitalizations in Type 2 Diabetes

Patients with type 2 diabetes who received sodium-glucose co-transporter 2 inhibitors vs dipeptidyl peptidase-4 inhibitors had a lower risk for heart failure hospitalizations.

Heart Failure, Arrhythmia Risk Increased With Zoledronic Acid

Heart Failure, Arrhythmia Risk Increased With Zoledronic Acid

Patients treated with zoledronic acid had a higher risk for atrial fibrillation and other arrhythmias as well as heart failure vs untreated patients.

Heart Failure: Fixed-Dose vs Off-Label Combos for Black Patients

Heart Failure: Fixed-Dose vs Off-Label Combos for Black Patients

Study finds genuine difference between a fixed-dose combination of isosorbide dinitrate plus hydralazine HCl and an off-label combination of the separate generic drugs for the treatment of heart failure in African American patients.

Spironolactone Oral Suspension Formulation Approved by FDA

Spironolactone Oral Suspension Formulation Approved by FDA

The FDA has approved CaroSpir, the first oral liquid formulation of spironolactone for hypertension and heart failure treatment.

Beta-Blockers Reduce CV Mortality in Heart Failure With Preserved Ejection Fraction

Beta-Blockers Reduce CV Mortality in Heart Failure With Preserved Ejection Fraction

Most pharmacotherapies appear not to have significant effect on all-cause or cardiovascular mortality in heart failure with preserved ejection fraction.

Gene Editing May Provide New Treatment Option for Hypertrophic Cardiomyopathy

Gene Editing May Provide New Treatment Option for Hypertrophic Cardiomyopathy

Researchers have used a gene-editing tool to repair the segment of DNA that causes hypertrophic cardiomyopathy.

Heart Failure in Type 2 Diabetes: Improving the Risk Model

Heart Failure in Type 2 Diabetes: Improving the Risk Model

N-terminal pro-B-type natriuretic peptide showed the strongest association with heart failure in patients with type 2 diabetes.

Childhood Asthma Linked With Increased Left Ventricular Mass In Adulthood

Childhood Asthma Linked With Increased Left Ventricular Mass In Adulthood

Greater left ventricle mass and left ventricle mass indexed to height were found in participants with a history of childhood asthma.

Can Beta-Blockers Reduce Mortality in Acute Myocardial Infarction Without Heart Failure?

Can Beta-Blockers Reduce Mortality in Acute Myocardial Infarction Without Heart Failure?

In patients with acute myocardial infarction without heart failure, beta-blockers did not reduce mortality risk at 1 year.

Subclinical Myocardial Damage in Obesity May Be Mitigated by Physical Activity

Subclinical Myocardial Damage in Obesity May Be Mitigated by Physical Activity

Individuals who had the lowest levels of recommended physical activity had elevated levels of high-sensitivity cardiac troponin T.

Exercise Capacity in Heart Failure With Reduced Ejection Fraction Not Improved With Iron Supplementation

Exercise Capacity in Heart Failure With Reduced Ejection Fraction Not Improved With Iron Supplementation

Patients with heart failure with reduced ejection fraction and iron deficiency do not benefit from iron supplementation.

Acute Heart Failure Mortality Increased With Morphine

Acute Heart Failure Mortality Increased With Morphine

Patients with acute heart failure who received intravenous morphine in the emergency department had higher mortality compared with patients who did not receive morphine.

Heart Failure Risk Increased With Fewer Menstrual Cycles

Heart Failure Risk Increased With Fewer Menstrual Cycles

Women with fewer menstrual cycles are at a higher risk for incident heart failure.

Ivabradine in Heart Failure With Preserved Ejection Fraction

Ivabradine in Heart Failure With Preserved Ejection Fraction

Ivabradine did not improve exercise capacity, diastolic function, or NT-proBNP levels in patients with heart failure with preserved ejection fraction.

Newly Diagnosed Atrial Fibrillation Benefits From Rivaroxaban, Dabigatran

Newly Diagnosed Atrial Fibrillation Benefits From Rivaroxaban, Dabigatran

Direct oral anticoagulation reduced the risk of congestive heart failure admissions and all-cause mortality in both genders.

Parenteral Nutrition in Comorbid Congestive Heart Failure Outcomes

Parenteral Nutrition in Comorbid Congestive Heart Failure Outcomes

Patients with comorbid congestive heart failure who received parenteral nutrition experienced increased negative outcomes in their hospital stay.

HIV Infection's Impact on HF: Reduced EF vs Preserved EF in ART

HIV Infection's Impact on HF: Reduced EF vs Preserved EF in ART

HIV poses higher risks of heart failure even at younger ages of infection, and 25% of all new cases in the United States occur in people between age 13 and 24.

Renin-Angiotensin System Inhibition Effect on Post-MI Mortality and New-Onset Atrial Fibrillation

Renin-Angiotensin System Inhibition Effect on Post-MI Mortality and New-Onset Atrial Fibrillation

Renin-angiotensin system inhibition was linked with a reduced 3-year risk of all-cause mortality in patients with congestive heart failure and atrial fibrillation.

Sacubitril/Valsartan Improves Glycemic Control in Comorbid Heart Failure and Diabetes

Sacubitril/Valsartan Improves Glycemic Control in Comorbid Heart Failure and Diabetes

HbA1c decreased by 0.16% in the enalapril group vs 0.26% in the sacubitril/valsartan group.

High TSH, Free T4 Concentrations Associated With Heart Failure Severity

High TSH, Free T4 Concentrations Associated With Heart Failure Severity

Subclinical hypothyroidism with TSH has been linked to worse survival in patients with preexisting heart failure, according to research.

Heart Failure Risk Linked With Bone Mineral Density in Men

Heart Failure Risk Linked With Bone Mineral Density in Men

Total hip bone mineral density was associated with heart failure risk in black and non-black men, with an interaction by race.

Nonischemic Heart Failure Risk Increased With Rheumatoid Arthritis

Nonischemic Heart Failure Risk Increased With Rheumatoid Arthritis

Researchers noted that the relative risk of heart failure increased following a patient's RA diagnosis.

Functional Status Decline Occurs at Least 2 Years Before Cardiovascular Events

Functional Status Decline Occurs at Least 2 Years Before Cardiovascular Events

A decline in function status occurred an average of 2 years before hospitalization for myocardial infarction, and 3 years before heart failure and stroke.

Higher Hospital Admissions in Takotsubo Cardiomyopathy During Late Summer

Higher Hospital Admissions in Takotsubo Cardiomyopathy During Late Summer

Although more women are admitted with Takotsubo cardiomyopathy, more men ultimately die.

Addressing Competency Requirements in Heart Failure and Transplant Training Programs

Addressing Competency Requirements in Heart Failure and Transplant Training Programs

The Advanced Training Statement for advanced heart failure and transplant cardiology consists of 6 general competencies.

Cardiac MRI Critical in Diagnosing Takotsubo Cardiomyopathy

Cardiac MRI Critical in Diagnosing Takotsubo Cardiomyopathy

Cardiac MRI should be used to differentiate Takotsubo cardiomyopathy from similar conditions.

Proton Pump Inhibitors Linked to Risk for Heart Failure, Death in CAD

Proton Pump Inhibitors Linked to Risk for Heart Failure, Death in CAD

The association between proton pump inhibitor use and incidence of heart failure and death was recently evaluated in a study.

Heart Failure, Atrial Fibrillation: Possible Markers for Mild Alzheimer's

Heart Failure, Atrial Fibrillation: Possible Markers for Mild Alzheimer's

Patients with both heart failure and atrial fibrillation had a pattern of milder Alzheimer's pathology.

Renin-Angiotensin System Inhibitors in Coronary Artery Disease Without Heart Failure

Renin-Angiotensin System Inhibitors in Coronary Artery Disease Without Heart Failure

Renin-angiotensin system inhibitors reduced cardiovascular events in patients with coronary artery disease when compared with placebo but not active controls.

Heart Failure Outcomes Improved With Respiratory Vaccination

Heart Failure Outcomes Improved With Respiratory Vaccination

Patients with heart failure may benefit from influenza vaccination.

Ventricular Tachycardia Ablation May Allow Patients to Reduce or Discontinue Amiodarone

Ventricular Tachycardia Ablation May Allow Patients to Reduce or Discontinue Amiodarone

A higher dose of amiodarone after ventricular tachycardia ablation was independently associated with a shorter time to death.

ICDs Rarely Affected by Smartphone Electromagnetic Interference

ICDs Rarely Affected by Smartphone Electromagnetic Interference

Of 307 patients, only 1 patient's ICD had electromagnetic interference produced by a telephone.

Speckle-Tracking Echocardiography May Help Identify LV Diastolic Function Phenotypes

Speckle-Tracking Echocardiography May Help Identify LV Diastolic Function Phenotypes

Data derived from speckle-tracking echocardiography and conventional methods and data derived solely from speckle-tracking echocardiography showed a high degree of statistical overlap.

LAA Closure Device in Atrial Fibrillation Yields High Success, Low Complication Rates

LAA Closure Device in Atrial Fibrillation Yields High Success, Low Complication Rates

The left atrial appendage closure device was found to have excellent success and low complication rates in a post-FDA approval study.

AHA: Pregnancy Management With Congenital Heart Disease

AHA: Pregnancy Management With Congenital Heart Disease

The American Heart Association presents recommendations for managing pregnancy in women with congenital heart disease.

Outcomes of Implantable Cardioverter-Defibrillators for Secondary Prevention

Outcomes of Implantable Cardioverter-Defibrillators for Secondary Prevention

In older adults who received implantable cardioverter-defibrillators as secondary prevention of sudden cardiac death, the risk of death was 21.8%.

FDA Issues Cybersecurity Alert for St. Jude Medical ICDs

FDA Issues Cybersecurity Alert for St. Jude Medical ICDs

St. Jude Medical implantable cardiac devices and the Merlin@home Transmitter may be vulnerable to cybersecurity attacks.

Left Ventricular Function Predicts Sepsis Short-Term Mortality

Left Ventricular Function Predicts Sepsis Short-Term Mortality

Left ventricular depression is known to occur in patients with severe sepsis or septic shock.

Sign Up for Free e-Newsletters